Zhichao Li

3.9k citations
119 papers · 2.5k indexed · 1 hit paper · h-index 30
Topics
Pulmonary Hypertension Research and Treatments (17 papers)Lung Cancer Diagnosis and Treatment (8 papers)Eicosanoids and Hypertension Pharmacology (7 papers)

In The Last Decade

Zhichao Li

112 papers receiving 2.5k citations

Hit Papers

ROS-mediated lysosomal membrane permeabilization and auto...202420262025202410203040

Peers

Zhichao Li
Comparison fields: 5 of 138
  • Molecular Biology 972
  • Pulmonary and Respiratory Medicine 609
  • Oncology 381
  • Cancer Research 361
  • Immunology 305
Replace Bin Wu with:
Bin Wu China
Linxi Chen China
Yuqin Chen China
Deborah A. Siwik United States
Chong Liu China
Xuesong Chen China
Yujing Liu China
Yunfeng Zhou China
Koichi Sato Japan
Zhichao Li relative to Bin Wu China Bin Wu's profile →
Citations per field
00.5×1.5×1.8×
Bin Wu · 1×
Citations per year

Countries citing papers authored by Zhichao Li

Since Specialization
Citations

This map shows the geographic impact of Zhichao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhichao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhichao Li more than expected).

Fields of papers citing papers by Zhichao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhichao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhichao Li. The network helps show where Zhichao Li may publish in the future.

Co-authorship network of co-authors of Zhichao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhichao Li. A scholar is included among the top collaborators of Zhichao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhichao Li. Zhichao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 6
5 5
6 11
7 21
8 8
9 10
10 37
11 11
12 14
13 13
14 5
15 16
16 28
17 44
18 47
19 22
20 26

About Zhichao Li

Zhichao Li is a scholar working on Biochemistry, Pulmonary and Respiratory Medicine and Cancer Research, having authored 119 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (17 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). The work is most often cited by research in Cancer Research (361 citations), Pulmonary and Respiratory Medicine (609 citations) and Complementary and alternative medicine (138 citations). Zhichao Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Ying Luo, Haiying Dong, Wen Niu, Dun-Quan Xu, Mingqing Dong, Yanxia Wang, Pengtao Zhao, Lei Yu, Manling Liu and Lisa Liu. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026